Abstract
Lipid nanoparticles have been clinically successful in particular recently within the vaccine field, but better tools are needed to analyze heterogeneities at the single particle level to progress drug delivery designs to the next level. Especially, liposomal nanocarriers are becoming increasingly complex e.g. by employing environmental cues for shedding their protective PEG layer, however a detailed mechanistic understanding of how the dePEGylation varies from liposome-to-liposome is still missing. Here we present the development of a fluorescence microscopy based assay capable of detecting the enzyme mediated dePEGylation of individual liposomes. We employ this methodology to understand how enzyme type-, concentration- and incubation time, in addition to liposome size, affects the dePEGylation at the single particle level.
| Original language | English |
|---|---|
| Journal | European Journal of Pharmaceutics and Biopharmaceutics |
| Volume | 171 |
| Pages (from-to) | 80-89 |
| ISSN | 0939-6411 |
| DOIs | |
| Publication status | Published - 2022 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Liposomal nanocarriers
- Enzyme mediated dePEGylation
- Single liposome measurements
- Quantitative flourescence microscopy
- Liposome heterogeneity
Fingerprint
Dive into the research topics of 'Quantifying the heterogeneity of enzymatic dePEGyaltion of liposomal nanocarrier systems'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver